0 Yorumlar
0 hisse senetleri
773 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Cancer Monoclonal Antibodies Market Size, Share, Growth Trends and Forecast 2031Cancer treatment is undergoing a significant transformation as targeted biologic therapies gain greater importance in oncology care. Rising cancer incidence, an aging global population, and increasing demand for more precise treatment approaches are strengthening the adoption of advanced antibody-based therapies. The Cancer Monoclonal Antibodies Market was valued at US$ 167,627.55 million in...0 Yorumlar 0 hisse senetleri 446 Views 0 önizleme
-
CD38 Monoclonal Antibodies Market Role in Personalized Cancer Treatment 2034Increasing use of combination treatment regimens is supporting the CD38 Monoclonal Antibodies Market. CD38-targeted therapies are being evaluated alongside other antimyeloma medicines to improve treatment responses and address different disease mechanisms. The CD38 Monoclonal Antibodies Market size is expected to reach US$ 20.63 Billion by 2034 from US$ 8.99 Billion in 2025, registering a CAGR...0 Yorumlar 0 hisse senetleri 327 Views 0 önizleme
-
Chinese Hamster Ovary Monoclonal Antibodies Market Outlook: Biopharmaceutical Trends & Growth ForecastAccording to the latest report published by Data Bridge Market Research, the Chinese Hamster Ovary (CHO) Monoclonal Antibodies Market CAGR Value The global Chinese hamster ovary (CHO) monoclonal antibodies market size was valued at USD 152.47 Million in 2024 and is expected to reach USD 309.82 Million by 2032, at a CAGR of 9.27% during the forecast period This...0 Yorumlar 0 hisse senetleri 67 Views 0 önizleme
-
Global Therapeutic Monoclonal Antibodies Market Set to Reach USD 415.5 Billion by 2032, Growing at 11.0% CAGRGlobal therapeutic monoclonal antibodies drug market size was valued at USD 175.3 billion in 2024. The market is projected to grow from USD 195.1 billion in 2025 to USD 415.5 billion by 2032, exhibiting a CAGR of 11.0% during the forecast period. Therapeutic monoclonal antibodies (mAbs) are laboratory-engineered proteins designed to bind to specific targets, such as cancer cells or inflammatory...0 Yorumlar 0 hisse senetleri 456 Views 0 önizleme
-
How Monoclonal Antibodies and Vaccines Are Shaping the Product LandscapeThe GCC Downstream Processing market is expanding as biopharmaceutical manufacturers invest in advanced purification and separation technologies to address the rising incidence of chronic diseases and improve patient outcomes. The market was valued at USD 2.5 billion in 2024 and is projected to reach USD 5.0 billion by 2035, growing at a CAGR of 7.2%. The GCC Downstream Processing Market...0 Yorumlar 0 hisse senetleri 345 Views 0 önizleme
-
How Rising Chronic Disease Prevalence and Cost-Effective Treatment Demands Are Driving the Global Biosimilar Monoclonal Antibodies MarketThe global Biosimilar Monoclonal Antibodies market is expanding as pharmaceutical companies, hospitals, and clinics invest in advanced biosimilar therapies to address the rising incidence of oncology, autoimmune diseases, and chronic conditions while reducing healthcare costs. The market was valued at USD 12.78 billion in 2023 and is projected to reach USD 32.0 billion by 2032, growing at a...0 Yorumlar 0 hisse senetleri 369 Views 0 önizleme
-
Monoclonal Antibodies In Veterinary Health Market: Competitive LandscapeThe global monoclonal antibodies in veterinary health market was valued at USD 785.71 million in 2022 and is projected to reach USD 3,425.91 million by 2032, expanding at a CAGR of 15.98% from 2023 to 2032. These findings come from the latest Polaris Market Research study, Global Monoclonal Antibodies in Veterinary Health Market, which evaluates the factors shaping demand, the segments and...0 Yorumlar 0 hisse senetleri 165 Views 0 önizleme
-
Recombinant Protein Therapeutics and Monoclonal Antibodies: Building a Comprehensive Biopharmaceutical Framework in ChinaThe management of serious diseases requires a sophisticated approach that combines advanced biologic therapies with personalized treatment strategies. At the core of this approach are Recombinant Protein Therapeutics and Monoclonal Antibodies , which work together to provide comprehensive treatment options for patients with cancer, autoimmune diseases, and other conditions....0 Yorumlar 0 hisse senetleri 873 Views 0 önizleme
-
Targeted Monoclonal Antibodies and Anti-NGF Therapeutics in Severe Osteoarthritis PainPioneering novel neuro-pathway inhibition to manage severe, chronic osteoarthritis pain resistant to conventional analgesics is driving high-value pharmaceutical R&D. Detailed analysis within the Osteoarthritis Market report reveals how anti-nerve growth factor (anti-NGF) monoclonal antibodies disrupt peripheral pain signaling pathways. Blocking NGF binding to TrkA receptors delivers...0 Yorumlar 0 hisse senetleri 75 Views 0 önizleme
-
Antibody Production Market Growth Fueled by Therapeutic ApplicationsSubheadline: Fact.MR forecasts the Antibody Production Market to grow from US$19.0 billion in 2026 to US$55.8 billion by 2036 at 11.4% CAGR. September 18, 2026 The global Antibody Production Market is projected to reach US$55.8 billion by 2036, rising from approximately US$19.0 billion in 2026 at a CAGR of 11.4%, according to Fact.MR analysis. The market was valued at approximately US$17.0...0 Yorumlar 0 hisse senetleri 797 Views 0 önizleme
-
CHST15 Antibody Market Growth Factors and Emerging TechnologiesThe global CHST15 antibody market is gaining significant momentum due to the increasing focus on cancer research, molecular diagnostics, and targeted therapeutic development. CHST15 antibodies are widely utilized in biomedical research to study carbohydrate sulfotransferase 15 expression and its role in tumor progression, fibrosis, and inflammatory diseases. Growing investments in biotechnology...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Global Biopharmaceutical and Bio-CDMO Market Growing at 14.2% CAGR Through 2032According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme
-
Immunotherapy Drugs Market Growth and the Search for More Targeted TreatmentsA growing disease burden is changing the economics and direction of modern drug development. As cancer and chronic immune-related conditions become more widespread, healthcare systems are looking for therapies that can deliver more targeted responses. This shift is creating a powerful growth environment for the Immunotherapy Drugs Market, which reached USD 285.7 billion in 2025 and is expected...0 Yorumlar 0 hisse senetleri 562 Views 0 önizleme
-
Lymphoma Treatment Market Growth Potential Driven by Advances in Cancer TherapeuticsThe lymphoma treatment market is witnessing significant growth as healthcare providers increasingly focus on improving outcomes for patients diagnosed with Hodgkin lymphoma and non-Hodgkin lymphoma. Rising cancer prevalence, advancements in oncology research, and the growing adoption of innovative treatment approaches are contributing to the expansion of the market. The development of targeted...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
Arama Sonuçları
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek